DiaMedica Therapeutics (DMAC) Enterprise Value (2018 - 2019)
Historic Enterprise Value for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q3 2019 value amounting to -$9.7 million.
- DiaMedica Therapeutics' Enterprise Value fell 14994.87% to -$9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$9.7 million, marking a year-over-year decrease of 14994.87%. This contributed to the annual value of -$16.8 million for FY2018, which is N/A changed from last year.
- According to the latest figures from Q3 2019, DiaMedica Therapeutics' Enterprise Value is -$9.7 million, which was down 14994.87% from -$11.0 million recorded in Q2 2019.
- DiaMedica Therapeutics' 5-year Enterprise Value high stood at -$3.9 million for Q3 2018, and its period low was -$16.8 million during Q4 2018.